sábado, 11 de julio de 2026
Medicare Advantage Insurers Deny Prior Authorization Requests for Post Acute Care at Substantially Higher Rates Than the Overall Denial Rate Authors: Jeannie Fuglesten Biniek, Meredith Freed, and Juliette Cubanski Published: Jul 6, 2026
https://www.kff.org/medicare/medicare-advantage-insurers-deny-prior-authorization-requests-for-post-acute-care-at-substantially-higher-rates-than-the-overall-denial-rate/?utm_campaign=KFF-This-Week&utm_medium=email&_hsenc=p2ANqtz-8q_Nuo4kyAmqNj68572UGnfLqBZFQPZd8ljnqyHJfTVvGbK95eRDJcVyQFT9SrqxbL87EvhyUnfYmwmpvmVbI4VqMf5Q&_hsmi=427848216&utm_content=427848216&utm_source=hs_email
Prior authorization practices by health insurers have come under scrutiny in recent years, in part spurred by the public sentiment that delays and denials of care are a problem. According to KFF polling, about seven in ten insured adults say prior authorization is a burden. New evidence from the Office of Inspector General (OIG) within the Department of Health and Human Services documents the high rate of denials of prior authorization requests for certain post-acute care services in Medicare Advantage plans, which now enroll more than half of all Medicare beneficiaries.
Contraceptive Implants: Access and Coverage in the U.S. Published: Jul 8, 2026
https://www.kff.org/womens-health-policy/contraceptive-implants/?utm_campaign=KFF-This-Week&utm_medium=email&_hsenc=p2ANqtz--up-u2cKBPE8mRPiOQzvr7oBEOQyAN3_Vm365y_aKQoCw7zzoov5G5Vlm_-aKSiFXR_8W9RQNIBXFQO1--04Yl9HQEHg&_hsmi=427848216&utm_content=427848216&utm_source=hs_email
The contraceptive implant is the most effective reversible birth control method available. Implants, along with intrauterine devices (IUDs), are known as long-acting reversible contraception (LARCs) because they can be used to prevent pregnancy for several years and can be removed at any time. Implants have been available since the 1990s and have undergone substantial design modifications since their debut. The newest generation implant was introduced to the U.S. market in 2006 and remains the only contraceptive implant available in the U.S. Barriers to implant use include limited awareness and availability, high up-front costs for clinicians to stock the device, and required insertion and removal by a trained clinician. This fact sheet provides an overview of contraceptive implants including use, availability, and financing.
How much and why ACA Marketplace premiums are going up in 2027 By Matt McGough, Jared Ortaliza, Ashley Ferguson, Imani Telesford, Shameek Rakshit, Emma Wager Twitter, Lynne Cotter, and Cynthia Cox KFF July 8, 2026
https://www.healthsystemtracker.org/brief/how-much-and-why-aca-marketplace-premiums-are-going-up-in-2027/?utm_campaign=KFF-This-Week&utm_medium=email&_hsenc=p2ANqtz-9M6CLEki8FyENsvAAD-AK55xRDXfS4c_Ekvhih96996bSLVMfQnGMqK9sT2qobGZuD4rcKXfpPaMUkIrSXGkc3gOaeIA&_hsmi=427848216&utm_content=427848216&utm_source=hs_email
Every spring and summer, health insurers submit rate filings to state regulators detailing expectations and premium rate changes for individual market health plans for the coming year. This analysis focuses on individual market filings for plans selling Affordable Care Act (ACA) Marketplace coverage. These filings provide insight into what factors insurers expect will drive health costs for the coming year. The individual market is mostly comprised of people enrolled in Affordable Care Act (ACA)-compliant health plans, particularly those sold through the Marketplaces (Healthcare.gov and state-run platforms like Covered California). While less than 10% of Americans get their health coverage through the individual market, many of the factors driving premiums in this market – like growth in hospital or pharmaceutical costs – are similar across all private plans, and the detailed filings available for ACA-compliant coverage provide insight into these cost drivers. There are also issues unique to ACA Marketplace plans, including federal premium assistance for most purchasers and regulations governing how they operate.
Suscribirse a:
Entradas (Atom)

